GE and Lilly Partner on Alzheimer s Diagnostics, Therapeutics

genomeweb
360dx

GE and Lilly Partner on Alzheimer s Diagnostics, Therapeutics

Apr 19, 2005

NEW YORK, April 19 (GenomeWeb News) - General Electric, through its Global Research and GE Healthcare units, has inked a research collaboration with Eli Lilly for the discovery of diagnostics and therapeutics for Alzheimer's disease, the companies said today.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

New Method Traces Demographic History of Admixed Populations Using Genome Data
Zika Virus Genomes Elucidate Disease Spread in Central America, Mexico
Functional Assays Improve Classification of Potential Cystic Fibrosis Risk Variants
Cancer Increase Reported in Families With Tau Mutation-Associated Neurodegeneration
Precipio Inks Distribution Deal With Italy's Euroclone Diagnostica
Merck, Foundation Medicine to Develop Companion Diagnostics for Immunotherapy

The Scan

Make Sense of It All

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

Variations on Results

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

This Week in Nature

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

Of Many Minds

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Main menu